Dave Gennert (@DaveGennert) header
Dave Gennert (@DaveGennert) profile picture

Scientific pubs & editing 📖, now @InSilicoMeds 💊, PhD @StanfordMed Genetics 🧬, fanatic for @RedSox ⚾️ (he/him) | tweets/opinions my own

Joined March 2018
Photo by Dave Gennert (@DaveGennert)Photo by Dave Gennert (@DaveGennert)Photo by Dave Gennert (@DaveGennert)Photo by Dave Gennert (@DaveGennert)Photo by Dave Gennert (@DaveGennert)Photo by Dave Gennert (@DaveGennert)Photo by Dave Gennert (@DaveGennert)Photo by Dave Gennert (@DaveGennert)Photo by Dave Gennert (@DaveGennert)Photo by Dave Gennert (@DaveGennert)
Leveraging #mtdna for #leukemia clonal evo & tracking-- awesome work from @livius_tacitus & Cathy Wu @DanaFarber out now in @BCD_AACR! One of those stories I was so excited to see develop as an editor, I'm happy for all authors & BCD realizing this cool tech/omics/clinical work!
👋👋👋 Mitochondrial DNA mutations - how do we use them productively for understanding #clonal #evolution in #leukemia? How do they relate to somatic mutations? What about rare cells? Today, I'd like to share my recent #singlecell work in @BCD_AACR doi.org/10.1158/2643-3230.BC… /n
1
4
353
How's that saying go? "You leave your job as an editor twice. Once when you stop going to work. And a second time, a bit later on, when the journal publishes the last manuscript you handled." Or something like that. Now I can rest...
2
2
78
Very proud to have helped compile this @AACR Publications Collection on #disparities in cancer. So much excellent work being done to understand what drives differences in disease biology, access to care, and response to therapy. #ASCO24
Attending #ASCO24? Read the latest collection on Disparities in Cancer from the AACR Journals: bit.ly/4c0BRSj
3
3
770
Congratulations to Owen Witte for receiving this year's @AACR Award for Outstanding Achievement in Blood Cancer Research at #AACR24! Dr. Witte sat down with us for a Q&A on his storied history in translational research, out NOW: bit.ly/4apQuOI
2
2
450
Hanging up my @BCD_AACR editor hat. THANK YOU to all authors who trusted me/us w/ your work & put faith in a new journal. Sci pub'ing may have flaws but there isn't a more dedicated team than @_TanyaBondar_ et al giving each article deserved consideration. Excited for its future!
12
755
We are grateful to the entire @BCD_AACR team for developing this meeting to showcase cutting-edge preclinical and clinical findings in the fields of cancer genomics and epigenetics, precursor conditions, tumor microenvironment, immunotherapy, and precision medicine. #AACRbcd24
#AACRbcd24 cochair Riccardo Dalla-Favera closed the AACR Blood Cancer Discovery Symposium this afternoon in Boston. We thank Dr. Dalla-Favera, his cochair Kenneth Anderson, the presenters, and all of the attendees for their contributions to a great meeting. @BCD_AACR
1
4
12
2,825
Wrapping up #AACRbcd24, Ben Ebert @DanaFarber takes us through his lab's work screening for disease-associated TFs susceptible to Ub-ligase degradation. Check out his work in @BCD_AACR characterizing one such interaction, ZMYM2 degraded by avadomide+CRBN: aacrjournals.org/bloodcancer…
4
6
780
A whirlwind overview of #myeloma #immunotherapy developments & targets from @ESmithMDPhD at #AACRbcd24. Highlighting work with @fdezdelarrea & @BrentjensRenier on BCMA+GPRC5D targeting to avoid antigen escape in MM @BCD_AACR: aacrjournals.org/bloodcancer… 1/3
1
3
4
1,145
Showcasing work from @marta_chesi & @Leif_Bergsagel in @BCD_AACR on combo therapies w/ BsAb vs models of #myeloma to avoid #TcellExhaustion in hi-burden disease: aacrjournals.org/bloodcancer… 2/3 #AACRbcd24 #mmsm
1
1
1
304
Dr Smith showing off @MadhavDhodapkar's work in @BCD_AACR profiling #myeloma #CARTcell patient bone marrow microenvironment to ID #singlecell correlates of response duration-- across CAR- TME, CAR+ Ts, myeloids, tumor cells: aacrjournals.org/bloodcancer… 3/3 #AACRbcd24 #mmsm
1
1
353
#CARTcell all-star @MarcelaMaus shares her latest in novel CAR targets & limiting irAEs at #AACRbcd24. Highlighting need to harmonize single-cell correlative analyses OUT NOW as InFocus in @BCD_AACR w/ @njharlen: aacrjournals.org/bloodcancer… 1/2
1
3
4
690
Dr. Maus showcased her stellar work with @StefanieBailey_ in @BCD_AACR finding dispensability of IFNg in #CARTcell response > now being taken to trials: aacrjournals.org/bloodcancer… 2/2 #AACRbcd24 #immunotherapy
3
7
820
.@BrunoPaiva_UNAV at #AACRbcd24 on the clinical importance & promise of high-sensitivity MRD & CTC detection & kinetics in #myeloma, for risk strat, Tx guidance, resistance mech. Read his recent @BCD_AACR article demonstrating this for Ide-cel response: aacrjournals.org/bloodcancer…
5
7
905
Nicole Gormley (@FDAOncology) shares regulatory perspective on #hemonc trial design at #AACRbcd24: defining biomarkers, surrogate endpoints. Read her NEW perspective out now w/ @IrenemGhobrial on these considerations for #myeloma trials: aacrjournals.org/bloodcancer…
3
2
807
🚨NEW work hot off the servers in @BCD_AACR from @DrTonyLetai & Shruti Bhatt unveiled at #AACRbcd24: #AML PDX models show lower apoptotic priming > broad resistance after acquired resistance to single Tx, & how to circumvent. doi.org/10.1158/2643-3230.BC… #leusm #apoptosis
In a study published in Blood Cancer Discovery (@BCD_AACR), collaborative work from @DrTonyLetai & the Letai Lab @danafarber & Bhatt lab sheds light on the biology of relapsed cancer cells by using mouse models of acute myeloid leukemia. #AML Read more ▶️ ms.spr.ly/6019cwufZ
1
2
7
1,183
Replying to @TheSFPM
@theSFPM Work led by Shruti Bhatt. One important lesson I learned is that no matter the drug, and no matter what other resistance mechanisms might be in play, it is likely that a resistant cancer cell also selects for decreased apoptotic priming.
1
64
And, I mean, check out that accompanying art: teapaw.org/_TanyaBondar_/status/1…
Artwork by Tetiana Sicharenko and DeepDream AI depicts mitochondrial apoptosis priming as Charon, the ferryman who transports souls of the deceased across the River Styx to the underworld, thereby setting a threshold between life and death. @DrTonyLetai
54
.@iannisaifantis1 presents awesome work at #AACRbcd24 discussing the regulation of T cell interactions in #myeloid maligs. Read his recent review in @BCD_AACR on the role of inflammation in myeloid disease: doi.org/10.1158/2643-3230.BC… #leusm #AML #inflammation
1
2
8
1,030
At #AACRbcd24,@IrenemGhobrial shares experiences in early screening for #myeloma precursors-- lots more to learn in predicting prog, interaction w/ genetics & TME. Out NOW in @BCD_AACR, Irene leads discussion on MGUS/SMM clinical trials to answer those Qs: bit.ly/49KVrS4
5
5
1,370
10
20
2,368